GPX4 and neoplasm: Although ferroptosis is rare in T-reg cells, recent studies have shown that targeting GPX4 can disturb the immune homeostasis, promote the production of IL-1β and Th17 cell reaction, thus enhancing the anti-tumor immune function (Xu et al., 2021b).